U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06974916) titled 'EMBRACE Tremor BiFUS' on May 07.
Brief Summary: This is a post-market (Phase IV) randomized, controlled, blinded, multicenter study with the aim to determine the added value of staged bilateral Exablate thalamotomy compared to a group of patients on previous unilateral treatment combined with local standard medical treatment.
Study Start Date: March 11
Study Type: INTERVENTIONAL
Condition:
Essential Tremor
Intervention:
PROCEDURE: Staged bilateral Exablate thalamotomy
Staged bilateral Exablate thalamotomy in ET patients
OTHER: Local standard medical treatment after previous Exablate unilateral thalamotomy.
Local standard med...